2026 NPPES data Pharmacotherapy Pharmacist NPI 1013125889 PHARM.D.
Verify on CMS →

MOLLY MINZE, PHARM.D.

Pharmacotherapy Pharmacist in ABILENE, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
44
Medicare Part D claims · 14 beneficiaries · Pharmacotherapy Pharmacist avg: 397
Generic prescribing
39%
generic claims · 61% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

MOLLY MINZE, PHARM.D. filed 44 Medicare Part D claims in 2023 as a Pharmacotherapy Pharmacist in ABILENE, Texas, prescribing 39% generic.

44
Part D claims, 2023
39%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MOLLY MINZE, PHARM.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

44 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about MOLLY MINZE, PHARM.D.?

Quality data not reported

NPI registry status

Active

Issued 05/17/2007

NPI 1013125889

Primary specialty

Pharmacotherapy Pharmacist

Mid-sized

5,925 US NPIs in this specialty

Medicare Part D claims

44 89% vs specialty avg

2023 prescription claims

Specialty avg: 397

Specialty distribution in Texas

How Pharmacotherapy Pharmacist compares to other specialties among Texas providers

Texas providers

Pharmacotherapy Pharmacist share within Texas

1. Pharmacotherapy Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacotherapy Pharmacist share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacotherapy Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacotherapy Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MOLLY MINZE, PHARM.D. is a Pharmacotherapy Pharmacist provider practicing in ABILENE, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARM.D.. NPI: 1013125889. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MOLLY MINZE, PHARM.D. appears in the CMS NPPES registry as a Pharmacotherapy Pharmacist provider holding PHARM.D. credentials at 1718 PINE ST, ABILENE, TX, 79601, with a listed phone of (325) 676-7948. NPI 1013125889 was issued on 05/17/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MINZE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 44 prescription claims written by this provider, covering 14 Medicare beneficiaries and totaling roughly $32K in drug spend, split 61% brand-name and 39% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacotherapy Pharmacist is a mid-sized specialty nationwide, with 5,925 enrolled providers across 53 states and an average of 397 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1718 PINE ST
ABILENE, TX 79601

Provider Details

NPI 1013125889
Specialty Pharmacotherapy Pharmacist
Credentials PHARM.D.
Gender Female
NPI Issued 05/17/2007

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to MOLLY MINZE, PHARM.D.. To verify MOLLY MINZE, PHARM.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

MOLLY MINZE, PHARM.D. — brand share 61.0%
Specialty average (est.)

61% brand-name claims vs 39% generic, on 44 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

44
Total Claims
$32K
Total Drug Cost
14
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
74
Total Day Supply
2,227
Brand vs Generic
61% brand / 39% generic
Brand Drug Cost
$31K
Generic Drug Cost
$239

Patient Demographics

Average Patient Age
69.7 years
Avg HCC Risk Score
1.16

Pharmacotherapy Pharmacist Overview

How MOLLY MINZE, PHARM.D. fits within the Pharmacotherapy Pharmacist landscape nationally.

5,925
Pharmacotherapy Pharmacist Providers in US
53
States with Pharmacotherapy Pharmacist
397
Avg Claims per Provider

MOLLY MINZE, PHARM.D.'s 44 claims are below the specialty average of 397.

Nearby Pharmacotherapy Pharmacist Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as MINZE.

Compare Pharmacotherapy Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MOLLY MINZE, PHARM.D.'s specialty?
MOLLY MINZE, PHARM.D. specializes in Pharmacotherapy Pharmacist and practices in ABILENE, Texas. Credentials: PHARM.D..
How much does MOLLY MINZE, PHARM.D. prescribe under Medicare Part D?
In 2023, MOLLY MINZE, PHARM.D. wrote 44 Medicare Part D claims totaling $32K in drug costs for 14 beneficiaries.
Where is MOLLY MINZE, PHARM.D. located?
MOLLY MINZE, PHARM.D. is located at 1718 PINE ST, ABILENE, TX, 79601. Phone: (325) 676-7948.
What is MOLLY MINZE, PHARM.D.'s NPI number?
MOLLY MINZE, PHARM.D.'s National Provider Identifier (NPI) is 1013125889, issued on 05/17/2007.
Does MOLLY MINZE, PHARM.D. prescribe more brand-name or generic drugs?
MOLLY MINZE, PHARM.D.'s prescribing is 61% brand-name and 39% generic drugs by claim count, with $31K in brand drug costs.
How many Pharmacotherapy Pharmacist providers are there in the US?
There are 5,925 Pharmacotherapy Pharmacist providers across 53 states in the US. The average Pharmacotherapy Pharmacist provider writes 397 Medicare Part D claims per year.
Does MOLLY MINZE, PHARM.D. accept Medicare?
MOLLY MINZE, PHARM.D. appears in CMS Medicare data with 44 Part D claims and 14 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MOLLY MINZE, PHARM.D.'s credentials?
MOLLY MINZE, PHARM.D.'s NPI is 1013125889 with credentials PHARM.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology